Merck Price
119.05₺ %-1.42-1.71
Last update:
High121.90 ₺
Low118.84 ₺
Volume10.92M
Market Cap294.03B
52W Low: 76.6647.05%52W High: 125.14
After-Hours119.33140.24%
- Open
- 121.50
- P/E
- 33.54
- Forward P/E
- 12.45
- P/B
- 6.41
- EPS (TTM)
- 3.55
- Forward EPS
- 9.5639
- Book Value
- 18.576
- Dividend Yield
- 2.72% (3.28)
- Dividend Date
- Jul 8, 2026
- 50-Day Avg
- 116.1816
- 200-Day Avg
- 104.7779
- Avg Volume (3M)
- 9.84M
- Shares Outstanding
- 2.47B
- Bid / Ask
- 119.04 / 119.04
- Analyst Rating
- 1.8 - Buy
- Next Earnings
- Aug 4, 2026
- Exchange
- NYSE
- Market State
- Closed
Company Data
Healthcare · Drug Manufacturers - General · 73000 employees
| Forward P/E | 12.45 |
|---|---|
| PEG Ratio | 5.54 |
| Price/Book | 6.41 |
| Beta | 0.22 |
| Earnings Per Share (EPS) | 3.55 |
| 52-Week Change | %47.05 |
| Enterprise Value (EV) | 337.5B |
| Shares Outstanding | 2.5B |
| Last Dividend | 0.85 (March 16, 2026) |
| Insider Ownership | %0.06 |
| Institutional Ownership | %82.29 |
| Net Profit Margin | %13.59 |
|---|---|
| Operating Margin | %38.6 |
| Return on Equity (ROE) | %18.94 |
| Return on Assets (ROA) | %12.58 |
| Revenue Growth | %4.9 |
| Debt/Equity | 106.94 |
| Current Ratio | 1.3 |
Analyst Outlook
- Average Price Target
- 129.74
- Target Range
- 100 – 150
- Number of Analysts
- 27
- Consensus
- Buy
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 4 | 15 | 10 | 0 | 0 |
Company data is sourced from Yahoo Finance and may be delayed; this is not investment advice.
Merck News
- Merck (MRK) Stock After 53% One-Year Gain Is DCF Signaling Further Upside Potential
- Merck's Belzutifan Combination Approved by FDA for Adjuvant Treatment of Renal Cell Carcinoma
- FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
- Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?
- Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- Sector Update: Healthcare Stocks Softer Late Afternoon
News is sourced from Yahoo Finance; headlines link to external sources.
What Is Merck?
Merck (MRK) is a company share traded on Borsa İstanbul. This page shows the last trade price, daily change, and intraday movement for Merck. Data is updated during Borsa İstanbul session hours.
The Merck price is determined by supply and demand. The company's financial performance, sector dynamics, and the macro environment are the main determinants.
Factors Affecting the Merck Price
- Company quarterly financial results (EBITDA, net profit)
- Sector dynamics and the competitive environment
- Dividend policy and capital increase decisions
- Inclusion in/exclusion from BIST indices (liquidity effect)
- Macro conditions and the foreign ownership ratio
Frequently Asked Questions
- What is Merck?
- Merck (MRK) is a publicly traded company on Borsa İstanbul. Its shares are bought and sold under the symbol "MRK".
- What are the Merck trading hours?
- On Borsa İstanbul, pre-opening is 09:40-09:55 and continuous trading is 10:00-18:00 (lunch break 13:00-14:00).
- How is the Merck price determined?
- It is the last trade price at which buyer and seller are matched in the continuous auction system. The best bid and ask levels in the order book indicate liquidity.
- When does dividend distribution for Merck occur?
- Merck dividend distribution is determined by a general assembly decision; for past-year dividends you can follow the PDP (KAP) announcements.